4.3 Mitophagy and metabolic-associated fatty liver diseases Metabolic associated fatty liver disease (MAFLD) refers to a series of diseases caused by multi-systemic metabolic dysfunction resulting in chronic liver damage, including hepatic steatosis, NAFLD, hepatic fibrosis, liver cirrhosis, hepatocellular carcinoma, and others ( In vitro , CP upregulates the protein levels of PGC-1, PPAR, PINK1, Parkin, ATG7, and LC3I/II in free FA (FFA)-induced NAFLD cell models, activates the PINK1-Parkin signaling pathway to promote mitophagy in liver cells, and inhibits FFA-induced OS and lipid accumulation
Activation of AMPK has been demonstrated to recruit p38 MAPK to the TAB1/AMPK-containing macromolecular complex, thus facilitating p38 MAPK activation in the ischemic heart (64)
You can learn more about safety considerations in this IV therapy safety guide
The Taquile Puno textiles are recognized by UNESCO as an Intangible Cultural Heritage
Pathophysiology, diagnosis, and management of endometriosis
Desensitization protocols may be a viable option for patients who specifically benefit from these antibiotics, particularly those who are immunosuppressed
